Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleAnkylosing Spondylitis

Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis

Kwi Young Kang, Min Kyung Chung, Ha Neul Kim, Yeon Sik Hong, Ji Hyeon Ju and Sung-Hwan Park
The Journal of Rheumatology March 2018, 45 (3) 349-356; DOI: https://doi.org/10.3899/jrheum.170079
Kwi Young Kang
From the Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea; Division of Rheumatology, Department of Internal Medicine, Incheon St. Mary’s Hospital, The Catholic University of Korea, Incheon, South Korea.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Kyung Chung
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ha Neul Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yeon Sik Hong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji Hyeon Ju
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: juji{at}catholic.ac.kr rapark{at}catholic.ac.kr
Sung-Hwan Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: juji{at}catholic.ac.kr rapark{at}catholic.ac.kr
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Abstract

Objective. To examine factors related to a low trabecular bone score (TBS) and the association between TBS and vertebral fractures in patients with ankylosing spondylitis (AS).

Methods. One hundred patients (all male, aged < 50 yrs) who fulfilled the modified New York criteria for the classification of AS were enrolled. The TBS and bone mineral density (BMD) were assessed using dual-energy X-ray absorptiometry. Clinical variables, inflammatory markers, and the presence of vertebral fractures were also assessed. Sacroiliitis grade and spinal structural damage were measured using the modified New York criteria and the Stoke Ankylosing Spondylitis Spine Score (SASSS).

Results. The mean TBS was 1.38 ± 0.13. The TBS showed a positive correlation with BMD at the lumbar spine, femoral neck, and total hip. TBS negatively correlated with SASSS, whereas BMD at the lumbar spine showed a positive correlation. A significant decrease in TBS values was observed in patients with spinal structural damage (p = 0.001). Univariate analysis identified disease duration, erythrocyte sedimentation rate (ESR), sacroiliitis grade, and SASSS as being associated with TBS. Multivariate analysis identified ESR and sacroiliitis grade as being independently associated with TBS (p = 0.006 and p < 0.001, respectively). Ten patients had morphometric vertebral fractures. The mean TBS was lower in patients with vertebral fractures than in age-matched patients without fractures (p = 0.028). Lower TBS predicted vertebral fractures (area under curve = 0.733, cutoff = 1.311).

Conclusion. The TBS in young male patients with AS is associated with the ESR and severity of sacroiliitis. The TBS may be useful as a tool for assessing osteoporosis in AS.

Key Indexing Terms:
  • TRABECULAR BONE SCORE
  • ANKYLOSING SPONDYLITIS
  • SACROILIITIS
  • ERYTHROCYTE SEDIMENTATION RATE

Ankylosing spondylitis (AS) is a chronic inflammatory disorder that involves mainly the spine and sacroiliac joints. Osteoporosis of the spine and peripheral bones is common in AS. The increased risk of osteoporosis in AS is related to both systemic inflammation and decreased mobility1. Patients with AS are at high risk of vertebral fracture; the risk of clinical vertebral fracture is 1.9–3.3 higher than that in subjects without AS2,3. The combination of spinal rigidity (due to formation of syndesmophytes) and osteoporosis within trabecular bone contributes to this high rate of vertebral fracture4.

It is unclear which imaging approach is most useful for diagnosing and monitoring osteoporosis in AS. To diagnose osteoporosis, bone strength (which reflects both bone quantity and bone quality) should be measured5. Dual-energy X-ray absorptiometry (DEXA) measurement of bone mineral density (BMD) at the hip and spine is most often used to establish or confirm a diagnosis of osteoporosis and to monitor patients6. Most data related to bone loss in patients with AS are based on studies using DEXA measurement of BMD.

One limitation of BMD is that it relates only to the density of bone, with no reference to bone quality (e.g., microarchitecture), which is a key determinant of bone strength7. DEXA-based BMD is a 2-dimensional approach and cannot distinguish between cortical and trabecular compartments. In AS, inflammation has a direct effect on the trabecular bone of the vertebrae, but not the cortical bone8. Therefore, BMD alone may lead to misinterpretation of inflammation-induced changes in bone strength in AS. Another limitation of BMD as measured by DEXA is that bony changes such as osteophytes can confound spinal measurements9. Syndesmophytes in patients with AS may also increase lumbar spine BMD as measured by DEXA10, as do osteophytes in patients with spinal osteoarthritis (OA). Therefore, a major challenge is to develop a clinically available, noninvasive technology for the accurate clinical evaluation of bone microarchitecture in AS.

The trabecular bone score (TBS) is a novel method used to evaluate bone microarchitecture. It is a textural index that evaluates pixel grey-level variations in the lumbar spine DEXA image, thereby providing an indirect index of trabecular microarchitecture11. The TBS derived from DEXA images correlates with the 3-D microarchitecture variables measured by quantitative computed tomography (QCT)12,13. A previous study shows that TBS is not influenced by spinal osteophytes, which may lead to an overestimation of BMD among patients with lumbar spine OA14. Another recent study shows that TBS is not affected by syndesmophytes in patients with axial spondyloarthritis (SpA)15.

To our knowledge, the risk factors associated with a low TBS in AS are unknown and no study has examined the association between TBS and vertebral fracture in patients with AS. Therefore, the aims of our present study were to identify the factors related to a low TBS in patients with AS and to examine the association between TBS and vertebral fracture.

MATERIALS AND METHODS

Study patients

This was a retrospective analysis of medical records obtained from Seoul Saint Mary’s Hospital and Incheon Saint Mary’s Hospital. The study enrolled patients with AS who fulfilled the modified New York criteria for the classification of AS16 and were followed up at the 2 participating hospitals between January 2011 and December 2014. All patients were > 20 years of age. To exclude the effects of sex and age, only male patients and patients < 50 years old were included. Exclusion criteria included psoriasis, inflammatory bowel disease, reactive arthritis, thyroid or parathyroid disorders, and chronic renal or liver disease. The study was approved by the ethics committees of Seoul St. Mary’s Hospital (XC13RIMI0129K) and Incheon St. Mary’s Hospital, Catholic University of Korea (XC13RIMI0129O).

Clinical data

Clinical assessments included demographic data (age, age at the time of AS diagnosis, and HLA-B27 status). Height and weight were measured at the time of DEXA measurements, and were used to calculate body mass index. Inflammatory markers [C-reactive protein and the erythrocyte sedimentation rate (ESR)] were measured at the time of DEXA examination. Medications were also recorded, including nonsteroidal antiinflammatory drugs, sulfasalazine, methotrexate, tumor necrosis factor inhibitors, calcium, and bisphosphonates. No patient received systemic glucocorticoids.

BMD measurements

Areal BMD was measured at the lumbar spine (L1 to L4) and left hip using DEXA (GEHC-Lunar Prodigy densitometer). All measurements were taken by experienced operators using the same machine and standardized procedures for participant positioning. BMD was measured at the lumbar spine (L1–L4) and the left hip (femoral neck and total proximal femur), and was expressed as the number of grams of bone mineral per square centimeter (g/cm2), the number of SD above or below the mean for a healthy 30-year-old adult of the same sex and ethnicity as the patient (T score), and the number of SD above or below the mean for an age-matched normal adult of the same sex (Z score). A position statement by the International Society for Clinical Densitometry (ISCD) recommends that Z scores be calculated in females prior to menopause and in males younger than 50 years. According to the ISCD recommendations, a low BMD is defined as a Z score ≤ −2.0 SD (compared with the age-matched mean)17. Data were compared with the densitometer manufacturer’s reference values.

TBS assessment

The TBS was analyzed using DEXA images of the lumbar spine (L1–L4). Lumbar spine DEXA images were reanalyzed in an operator-independent automated manner using TBS iNight software version 2.1 (Med-Imaps). The software uses the posterior-anterior images, including the BMD region of interest and edge detection; thus, the TBS is calculated over exactly the same region as the lumbar BMD assessment.

Radiographic scoring

Radiographs of the lumbar lateral spine and pelvis were obtained at the time of the DEXA test. Sacroiliitis was assessed by viewing images of the sacroiliac joint and was graded according to the New York criteria16 by a reader blinded to the clinical details of the patients. Radiographic scoring in the lumbar spine related to AS was assessed using the Stoke Ankylosing Spondylitis Spine Score (SASSS). The SASSS was calculated by scoring the anterior and posterior vertebral corners of the lumbar spinal segments, from T12 lower to S1 upper, with each segment scored from 0 to 3 points as follows: 0 = normal; 1 = erosion, sclerosis, or squaring; 2 = syndesmophyte formation; and 3 = a bridging syndesmophyte18. Thus, total scores ranged from 0 to 72. The number of syndesmophytes was assessed using the SASSS.

Assessment of vertebral fracture

Vertebral fracture was assessed on lateral radiographs of the lumbar spine (T12–L4) using the standardized semiquantitative method described by Genant, et al19 and defined as a ≥ 20% reduction in vertebral height. Grading was performed by 2 experienced investigators (K.Y. Kang and H.N. Kim), both of whom were blinded to the clinical details of the patients. There were few discrepancies, and the 2 investigators reached a consensus when these were found. The interobserver variability was calculated using Cohen’s kappa value (κ = 0.76).

Statistical analysis

Statistical analyses were performed using SPSS (version 21.0; SPSS Inc.). Continuous data were expressed as the mean ± SD and categorical data as percentages. Normally distributed variables were compared using an independent t test, and nonnormally distributed variables were compared using the Mann-Whitney U test. The chi-square test was used to compare categorical variables. Clinical variables and BMD values were compared in subgroups across tertiles of TBS using chi-square tests for categorical variables and Kruskal-Wallis nonparametric tests for continuous data. Spearman correlation coefficient was used to analyze the correlation between variables. Multiple linear regression models were used to assess the association between TBS and clinical variables. All variables with a p value < 0.05 in univariate linear regression were incorporated as explanatory variables (stepwise method). A receiver-operating characteristic (ROC) curve was constructed using the discriminant TBS for vertebral fracture. P < 0.05 was considered statistically significant.

RESULTS

The clinical characteristics of the study patients are shown in Table 1. The mean age was 34 ± 8 years and duration after diagnosis of AS was 6 ± 5 years. The mean SASSS and sacroiliitis grade were 9.5 ± 16.0 and 3.1 ± 0.6. Forty-two patients had 1 or more syndesmophytes. Among 100 patients, 19 had low BMD at the lumbar spine, 14 at the femoral neck, and 27 at the total hip. Thirty-four patients had a low BMD at any site (lumbar spine, femoral neck, and/or total hip). The mean TBS at the lumbar spine was 1.38 ± 0.13.

View this table:
  • View inline
  • View popup
Table 1.

Patient characteristics stratified according to the lumbar trabecular bone score. Values are mean ± SD or n (%).

TBS correlated with BMD values at the lumbar spine, femoral neck, and total hip (Table 2). TBS also correlated with the Z score at all sites. TBS showed a negative correlation with the grade of sacroiliitis. BMD at the lumbar spine correlated positively with SASSS and the number of syndesmophytes, whereas TBS showed a negative correlation. As for TBS, BMD at the femoral neck and total hip also showed a negative correlation with SASSS and number of syndesmophytes. A significant decrease in TBS values was observed in patients with spinal structural damage (p = 0.001), as shown in Figure 1. In contrast to TBS, BMD at the lumbar spine did not differ between the 2 groups.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Comparison of (A) TBS and (B) BMD values at the lumbar spine, (C) BMD values at the femoral neck, and (D) BMD values at the total hip among patients with and without spinal structural damage. ** p < 0.05. TBS: trabecular bone scores; BMD: bone mineral density.

View this table:
  • View inline
  • View popup
Table 2.

Correlation between the TBS, BMD, and radiographic damage. Data are given as r coefficient.

Univariate analysis revealed that TBS was associated with disease duration, ESR, the grade of sacroiliitis, and the SASSS (Table 3). Multivariate analysis showed that ESR and the grade of sacroiliitis were independently associated with TBS (p = 0.006 and p < 0.001, respectively).

View this table:
  • View inline
  • View popup
Table 3.

Linear regression analysis of the trabecular bone score in the lumbar spine.

Among the 100 patients examined, 10 (10%) had morphometric vertebral fractures. Eleven vertebral fractures were identified in 10 patients: seven grade 1 fractures and four grade 2 fractures. Therefore, we compared the TBS and the SASSS between patients with vertebral fracture and age-matched patients without vertebral fracture (Table 4). The mean TBS was lower in patients with vertebral fracture (p = 0.028). However, the SASSS was higher in patients with vertebral fracture (p = 0.018). The ROC curve for TBS as a discriminator of vertebral fracture is shown in Figure 2. We identified the best cutoff for TBS as 1.311, which yielded a sensitivity of 60% and a specificity of 93% for vertebral fractures. The area under the ROC curve was 0.733 (95% CI 0.491–0.975).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

The ROC curve of the TBS used to discriminate vertebral fractures. ROC: receiver-operating characteristic; TBS: trabecular bone scores; AUC: area under the curve.

View this table:
  • View inline
  • View popup
Table 4.

Comparison of the TBS and spinal damage at the lumbar spine among patients with lumbar vertebral fracture and age-matched patients without fracture. Values are mean ± SD.

DISCUSSION

Our cross-sectional study of young male patients with AS revealed that the severity of sacroiliitis and the level of ESR were associated with a low TBS. The TBS was lower in patients with AS with spinal damage than in those without. The results also showed that AS patients with vertebral fracture had a lower TBS than those without.

Chronic inflammation of musculoskeletal structures leads to structural damage to bone tissue, as well as symptoms such as pain and stiffness. The bone tissue directly exposed to inflammation (osteitis) in AS is the trabecular bone of the vertebrae8. Patients with AS have a high prevalence of osteoporosis in the vertebral bodies and an increased risk of fracture20,21,22, suggesting that chronic inflammation results in loss of trabecular bone mass. Disease activity in AS contributes to the rate of bone loss, and osteoporosis is considered a manifestation of the disease itself rather than a comorbidity23.

A US National Institutes of Health consensus development panel defined osteoporosis as a skeletal disorder characterized by compromised bone strength, thereby predisposing a person to increased risk of fracture5. BMD as measured by DEXA is the gold standard for the diagnosis and management of osteoporosis. However, BMD accounts for only 60–80% of bone strength; a number of skeletal features other than BMD contribute to bone strength and fracture risk24. Bone quality, as well as BMD, is involved in determining bone strength and predisposition to fracture. Bone quality is determined by bone microarchitecture, geometry, turnover, and mineralization25. The TBS is a recently developed analytical tool that performs grey-level texture measurements on lumbar spine DEXA images, thereby identifying information relating to trabecular microarchitecture. An earlier study showed that TBS correlates with the histomorphic trabecular microarchitecture of transiliac bone biopsies26. A low TBS is consistently associated with an increase in both the prevalence and incidence of fractures, and is partly independent of the clinical risk of fracture. In addition, TBS can predict fracture independently of fracture probability in the general population predicted using the FRAX algorithm27. A study showed that a low TBS is useful as a determinant of fracture risk, independent of BMD28. Also, osteophytes in cases of spinal OA increase the overall BMD value in the lumbar spine, whereas TBS is not affected by such artifacts14,29.

The European League Against Rheumatism makes the following recommendations regarding the use of imaging for the management of SpA: In patients with axial SpA without syndesmophytes in the lumbar spine on conventional radiography, osteoporosis should be assessed using hip DEXA and anterior-posterior spine DEXA; in patients with syndesmophytes in the lumbar spine on conventional radiography, osteoporosis should be assessed using hip DEXA supplemented by either spine DEXA (lateral projection) or possibly QCT of the spine30. Although spinal DEXA using a lateral view has the advantage of allowing selection of a trabecular zone in the center of the vertebral bodies, it has poor precision because of the difficulty in positioning the patients. Moreover, because of the overlap of the last rib and iliac crest, only L3 can be measured in some cases14,31. QCT cannot be performed routinely in a clinical setting because of the high radiation dose to the patient, the high cost, and limited access to such devices27. Therefore, a new tool that is unaffected by spinal damage is needed to assess osteoporosis and to predict fracture risk in AS.

The data presented herein suggest that the TBS is a useful tool for assessing osteoporosis in AS patients with spinal structural damage. BMD in the lumbar spine showed a positive correlation with spinal damage, while TBS showed a negative correlation with spinal damage and a positive correlation with BMD in the femoral neck and total hip. TBS was not affected by spinal structural damage in multivariate analysis. This is consistent with previous data from a study of axial SpA15. Taken together, these findings indicate that TBS as measured by DEXA, along with hip BMD, is a useful tool for assessing osteoporosis in AS, regardless of spinal structural damage.

The data presented herein also show that the ESR and the grade of sacroiliitis, which reflect the severity of cumulative inflammation, were independently associated with TBS after adjusting for confounding factors. Thus, TBS may reflect bone quality in the presence of chronic inflammation.

To the best of our knowledge, ours is the first study to examine the association between TBS and vertebral fracture in patients with AS. Low BMD is a strong risk factor for fractures in the general population32, but previous studies of the association between low BMD and fracture in patients with AS are inconsistent33,34,35,36. This may be related to both an overestimation of BMD because of the presence of syndesmophytes and insufficient reflection of changes in the quality of trabecular bone caused by chronic inflammation. Here, AS patients with vertebral fracture had a lower TBS than age-matched patients without fracture. This suggests that a low TBS could be related to vertebral fracture in patients with AS. However, we did not analyze whether the TBS could predict development of vertebral fractures because this study was of cross-sectional design. Further longitudinal studies are required to examine whether the TBS is predictive of vertebral fracture.

The data presented herein also suggest that spinal structural damage may contribute to the development of vertebral fractures because of poor bone quality, as well as biomechanical effects resulting from poor spinal mobility and hyperkyphosis. We found that spinal structural damage was greater in AS patients with vertebral fracture than in those without. This is consistent with previous studies showing an association between spinal radiographic damage and vertebral fracture34,37. Stiffening of the spine in AS contributes to vertebral fracture risk by reducing biomechanical competence. We found that spinal structural damage was also related to a low TBS and poor bone quality, suggesting that spinal structural damage, as well as stiffening of the spine, may increase the risk of osteoporosis and may contribute to the development of vertebral fracture in AS. Additionally, the prevalence of vertebral fractures in our present study was higher than that reported previously38. The difference in the prevalence of vertebral fracture between the 2 studies may be related to patient characteristics. For example, our patients had more severe structural damage, which could associate with a greater frequency of vertebral fracture.

TBS has an advantage in that it directly assesses the microarchitecture of trabecular bone at the lumbar spine, which is the main area of involvement in patients with AS. A previous study showed that sacroiliitis on MRI correlated with BMD at the femoral neck and total hip; however, sacroiliitis on MRI was not associated with lumbar BMD39. Thus, bone loss at the spine in AS may be because of the localized effects of inflammation. Therefore, assessment of bone microarchitecture in the spine using the TBS may be a better predictor of the risk of osteoporosis and vertebral fracture in AS than high-resolution peripheral QCT of peripheral joints.

Our study has several limitations. First, it was of cross-sectional design; thus, although we could assess associations, we could not determine a cause-effect relationship. Another limitation was the use of the SASSS system to quantify spinal structural damage. This system is limited in that it takes into account structural changes in the lumbar spine with no consideration of the cervical or thoracic spines. Additionally, we had no data regarding the history of smoking and alcohol use. Despite the possible effects of smoking and alcohol on TBS, we did not evaluate them because of a lack of baseline information. Also, we did not evaluate the subclinical gut involvement. Gut inflammation is considered a risk factor for osteoporosis in AS40. Finally, we included only young male patients with AS. Further studies including women and older patients are needed to fully explore factors associated with TBS.

The lumbar TBS is associated with the ESR and the severity of sacroiliitis in young male patients with AS. The TBS is lower in patients with spinal structural damage and in those with vertebral fracture. A combination of the TBS and hip BMD may improve assessment of osteoporosis in AS patients with spinal structural damage.

Footnotes

  • Supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning [NRF-2014R1A1A1006695], and a grant of the Korea Healthcare Technology R&D project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI16C2177].

  • Accepted for publication September 29, 2017.

REFERENCES

  1. 1.↵
    1. Briot K,
    2. Roux C
    . Inflammation, bone loss and fracture risk in spondyloarthritis. RMD Open 2015;1:e000052.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Vosse D,
    2. Landewé R,
    3. van der Heijde D,
    4. van der Linden S,
    5. van Staa TP,
    6. Geusens P
    . Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study. Ann Rheum Dis 2009;68:1839–42.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Muñoz-Ortego J,
    2. Vestergaard P,
    3. Rubio JB,
    4. Wordsworth P,
    5. Judge A,
    6. Javaid MK,
    7. et al.
    Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: a population-based cohort study. J Bone Miner Res 2014;29:1770–6.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Davey-Ranasinghe N,
    2. Deodhar A
    . Osteoporosis and vertebral fractures in ankylosing spondylitis. Curr Opin Rheumatol 2013;25:509–16.
    OpenUrl
  5. 5.↵
    1. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
    . Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785–95.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Cosman F,
    2. de Beur SJ,
    3. LeBoff MS,
    4. Lewiecki EM,
    5. Tanner B,
    6. Randall S,
    7. et al;
    8. National Osteoporosis Foundation
    . Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 2014;25:2359–81.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Bousson V,
    2. Bergot C,
    3. Sutter B,
    4. Levitz P,
    5. Cortet B;
    6. Scientific Committee of the Groupe de Recherche et d’Information sur les Ostéoporoses
    . Trabecular bone score (TBS): available knowledge, clinical relevance, and future prospects. Osteoporos Int 2012;23:1489–501.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Schett G
    . Structural bone changes in spondyloarthritis: mechanisms, clinical impact and therapeutic considerations. Am J Med Sci 2011;341:269–71.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Reid IR,
    2. Evans MC,
    3. Ames R,
    4. Wattie DJ
    . The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab 1991;72:1372–4.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Klingberg E,
    2. Lorentzon M,
    3. Gothlin J,
    4. Mellstrom D,
    5. Geijer M,
    6. Ohlsson C,
    7. et al.
    Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes. Arthritis Res Ther 2013;15:R179.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Silva BC,
    2. Leslie WD,
    3. Resch H,
    4. Lamy O,
    5. Lesnyak O,
    6. Binkley N,
    7. et al.
    Trabecular bone score: a noninvasive analytical method based upon the DXA image. J Bone Miner Res 2014;29:518–30.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Silva BC,
    2. Boutroy S,
    3. Zhang C,
    4. McMahon DJ,
    5. Zhou B,
    6. Wang J,
    7. et al.
    Trabecular bone score (TBS)—a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2013;98:1963–70.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Silva BC,
    2. Walker MD,
    3. Abraham A,
    4. Boutroy S,
    5. Zhang C,
    6. McMahon DJ,
    7. et al.
    Trabecular bone score is associated with volumetric bone density and microarchitecture as assessed by central QCT and HRpQCT in Chinese American and white women. J Clin Densitom 2013;16:554–61.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Kolta S,
    2. Briot K,
    3. Fechtenbaum J,
    4. Paternotte S,
    5. Armbrecht G,
    6. Felsenberg D,
    7. et al.
    TBS result is not affected by lumbar spine osteoarthritis. Osteoporos Int 2014;25:1759–64.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Wildberger L,
    2. Boyadzhieva V,
    3. Hans D,
    4. Stoilov N,
    5. Rashkov R,
    6. Aubry-Rozier B
    . Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis. Joint Bone Spine 2017;84:463–6.
    OpenUrl
  16. 16.↵
    1. van der Linden S,
    2. Valkenburg HA,
    3. Cats A
    . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361–8.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Baim S,
    2. Leonard MB,
    3. Bianchi ML,
    4. Hans DB,
    5. Kalkwarf HJ,
    6. Langman CB,
    7. et al.
    Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitom 2008;11:6–21.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Averns HL,
    2. Oxtoby J,
    3. Taylor HG,
    4. Jones PW,
    5. Dziedzic K,
    6. Dawes PT
    . Radiological outcome in ankylosing spondylitis: use of the Stoke Ankylosing Spondylitis Spine Score (SASSS). Br J Rheumatol 1996;35:373–6.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Genant HK,
    2. Wu CY,
    3. van Kuijk C,
    4. Nevitt MC
    . Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 1993;8:1137–48.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Kang KY,
    2. Kim IJ,
    3. Jung SM,
    4. Kwok SK,
    5. Ju JH,
    6. Park KS,
    7. et al.
    Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis. Arthritis Res Ther 2014;16:R124.
    OpenUrl
  21. 21.↵
    1. Klingberg E,
    2. Lorentzon M,
    3. Mellström D,
    4. Geijer M,
    5. Gothlin J,
    6. Hilme E,
    7. et al.
    Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment. Arthritis Res Ther 2012;14:R108.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Prieto-Alhambra D,
    2. Muñoz-Ortego J,
    3. De Vries F,
    4. Vosse D,
    5. Arden NK,
    6. Bowness P,
    7. et al.
    Ankylosing spondylitis confers substantially increased risk of clinical spine fractures: a nationwide case-control study. Osteoporos Int 2015;26:85–91.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Rosenbaum J,
    2. Chandran V
    . Management of comorbidities in ankylosing spondylitis. Am J Med Sci 2012;343:364–6.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Silva BC,
    2. Broy SB,
    3. Boutroy S,
    4. Schousboe JT,
    5. Shepherd JA,
    6. Leslie WD
    . Fracture risk prediction by non-BMD DXA measures: the 2015 ISCD Official Positions part 2: trabecular bone score. J Clin Densitom 2015;18:309–30.
    OpenUrlPubMed
  25. 25.↵
    1. Maricic M
    . Use of DXA-based technology for detection and assessment of risk of vertebral fracture in rheumatology practice. Curr Rheumatol Rep 2014;16:436.
    OpenUrl
  26. 26.↵
    1. Muschitz C,
    2. Kocijan R,
    3. Haschka J,
    4. Pahr D,
    5. Kaider A,
    6. Pietschmann P,
    7. et al.
    TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures. Bone 2015;79:259–66.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Harvey NC,
    2. Gluer CC,
    3. Binkley N,
    4. McCloskey EV,
    5. Brandi ML,
    6. Cooper C,
    7. et al.
    Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice. Bone 2015;78:216–24.
    OpenUrl
  28. 28.↵
    1. Leslie WD,
    2. Aubry-Rozier B,
    3. Lix LM,
    4. Morin SN,
    5. Majumdar SR,
    6. Hans D
    . Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program. Bone 2014;67:10–4.
    OpenUrl
  29. 29.↵
    1. Dufour R,
    2. Winzenrieth R,
    3. Heraud A,
    4. Hans D,
    5. Mehsen N
    . Generation and validation of a normative, age-specific reference curve for lumbar spine trabecular bone score (TBS) in French women. Osteoporos Int 2013;24:2837–46.
    OpenUrl
  30. 30.↵
    1. Mandl P,
    2. Navarro-Compán V,
    3. Terslev L,
    4. Aegerter P,
    5. van der Heijde D,
    6. D’Agostino MA,
    7. et al.
    EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann Rheum Dis 2015;74:1327–39.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Larnach TA,
    2. Boyd SJ,
    3. Smart RC,
    4. Butler SP,
    5. Rohl PG,
    6. Diamond TH
    . Reproducibility of lateral spine scans using dual energy X-ray absorptiometry. Calcif Tissue Int 1992;51:255–8.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Briot K,
    2. Roux C
    . What is the role of DXA, QUS and bone markers in fracture prediction, treatment allocation and monitoring? Best Pract Res Clin Rheumatol 2005;19:951–64.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Arends S,
    2. Spoorenberg A,
    3. Bruyn GA,
    4. Houtman PM,
    5. Leijsma MK,
    6. Kallenberg CG,
    7. et al.
    The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 2011;22:1431–9.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Ghozlani I,
    2. Ghazi M,
    3. Nouijai A,
    4. Mounach A,
    5. Rezqi A,
    6. Achemlal L,
    7. et al.
    Prevalence and risk factors of osteoporosis and vertebral fractures in patients with ankylosing spondylitis. Bone 2009;44:772–6.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Jun JB,
    2. Joo KB,
    3. Her MY,
    4. Kim TH,
    5. Bae SC,
    6. Yoo DH,
    7. et al.
    Femoral bone mineral density is associated with vertebral fractures in patients with ankylosing spondylitis: a cross-sectional study. J Rheumatol 2006;33:1637–41.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Klingberg E,
    2. Geijer M,
    3. Gothlin J,
    4. Mellstrom D,
    5. Lorentzon M,
    6. Hilme E,
    7. et al.
    Vertebral fractures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skeleton. J Rheumatol 2012;39:1987–95.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Geusens P,
    2. De Winter L,
    3. Quaden D,
    4. Vanhoof J,
    5. Vosse D,
    6. van den Bergh J,
    7. et al.
    The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma. Arthritis Res Ther 2015;17:294.
    OpenUrl
  38. 38.↵
    1. van der Weijden MA,
    2. van der Horst-Bruinsma IE,
    3. van Denderen JC,
    4. Dijkmans BA,
    5. Heymans MW,
    6. Lems WF
    . High frequency of vertebral fractures in early spondylarthropathies. Osteoporos Int 2012;23:1683–90.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Kim HN,
    2. Jung JY,
    3. Hong YS,
    4. Park SH,
    5. Kang KY
    . Severe bone marrow edema on sacroiliac joint MRI increases the risk of low BMD in patients with axial spondyloarthritis. Sci Rep 2016;6:22158.
    OpenUrl
  40. 40.↵
    1. Roux C
    . Osteoporosis in inflammatory joint diseases. Osteoporos Int 2011;22:421–33.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 45, Issue 3
1 Mar 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis
Kwi Young Kang, Min Kyung Chung, Ha Neul Kim, Yeon Sik Hong, Ji Hyeon Ju, Sung-Hwan Park
The Journal of Rheumatology Mar 2018, 45 (3) 349-356; DOI: 10.3899/jrheum.170079

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Severity of Sacroiliitis and Erythrocyte Sedimentation Rate are Associated with a Low Trabecular Bone Score in Young Male Patients with Ankylosing Spondylitis
Kwi Young Kang, Min Kyung Chung, Ha Neul Kim, Yeon Sik Hong, Ji Hyeon Ju, Sung-Hwan Park
The Journal of Rheumatology Mar 2018, 45 (3) 349-356; DOI: 10.3899/jrheum.170079
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

TRABECULAR BONE SCORE
ANKYLOSING SPONDYLITIS
SACROILIITIS
ERYTHROCYTE SEDIMENTATION RATE

Related Articles

Cited By...

More in this TOC Section

  • Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era
  • Pregnancy Outcomes in Couples with Males Exposed to Longterm Anti–tumor Necrosis Factor–α Inhibitor Therapies: A Prospective Study
  • Value of Color Doppler Ultrasound Assessment of Sacroiliac Joints in Patients with Inflammatory Low Back Pain
Show more Ankylosing Spondylitis

Similar Articles

Keywords

  • TRABECULAR BONE SCORE
  • ankylosing spondylitis
  • sacroiliitis
  • ERYTHROCYTE SEDIMENTATION RATE

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire